@misc{Jarecka_Maria_Therapeutic_2005,
 author={Jarecka, Maria and Borowicz, Piotr},
 volume={71},
 number={4},
 copyright={Creative Commons Attribution BY-SA 4.0 license},
 journal={Biotechnologia, vol.71, 4 (2005)-.},
 howpublished={online},
 year={2005},
 publisher={Committee on Biotechnology PAS},
 publisher={Institute of Bioorganic Chemistry PAS},
 language={pol},
 abstract={Therapeutic applications and global market of commercialized biopharmaceuticals-recombinant medicines have been presented. The first and second generation of genetically engineered products such as: hormones, cytokines, blood factors, monoclonal antibodies and others approved to date or undergoing clinical investigations in the US and EU have been described. They are used to treat or prevent many diseases, including: diabetes, growth deficiency, anemia, cardio-vascular disorders and, especially, immune-mediated inflammatory disorders and various cancers. The authors have also presented current global biopharmaceutical market, leading biopharmaceuticals, the fastest growing recombinant protein categories and strategic market analysis and forecasts until 2010.},
 title={Therapeutic and market expectancy of recombinant medicines},
 type={Text},
 URL={http://rcin.org.pl/Content/88585/PDF/POZN271_115438_biotechnologia-2005-no4-jarecka.pdf},
 keywords={biotechnology},
}